TET2 c.4155dup ;(p.H1386Afs*15)

Variant ID: 4-106190876-T-TG

NM_001127208.2(TET2):c.4155dup;(p.H1386Afs*15)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm-blast phase.

Jci Insight
Wang, Xiaoli X; Rampal, Raajit K RK; Hu, Cing Siang CS; Tripodi, Joseph J; Farnoud, Noushin N; Petersen, Bruce B; Rossi, Michael R MR; Patel, Minal M; McGovern, Erin E; Najfeld, Vesna V; Iancu-Rubin, Camelia C; Lu, Min M; Davis, Andrew A; Kremyanskaya, Marina M; Weinberg, Rona Singer RS; Mascarenhas, John J; Hoffman, Ronald R
Publication Date: 2022-04-22

Variant appearance in text: TET2: 4154_4155insG
PubMed Link: 35259128
Variant Present in the following documents:
  • jciinsight-7-156534-s067.xlsx, sheet 1
View BVdb publication page



Applicability of next-generation sequencing to decalcified formalin-fixed and paraffin-embedded chronic myelomonocytic leukaemia samples.

International Journal Of Clinical And Experimental Pathology
Bernard, Veronica V; Gebauer, Niklas N; Dinh, Thomas T; Stegemann, Judith J; Feller, Alfred C AC; Merz, Hartmut H
Publication Date: 2014

Variant appearance in text: TET2: H1386AfsX15
PubMed Link: 24817963
Variant Present in the following documents:
  • Main text
View BVdb publication page